Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058849 · ClinicalTrials.gov registry record · Phase 2
Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
A Phase 2 study, sponsored by David Travis Thomas.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT02058849: Completed Phase 2 study, sponsored by David Travis Thomas.
NCT02058849 is a Phase 2 study that has completed, run by David Travis Thomas. The registered enrollment target is 13 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02058849, a Phase 2 study, has completed, sponsored by David Travis Thomas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators central hypothesis is that dietary nitrate supplementation in head and neck cancer patients receiving aggressive medical care will improve compliance with medical treatment by attenuating the loss of muscle mass and strength and reducing symptoms (mucositis) associated with treatment compared to patients receiving standard care with placebo.
Primary Outcome
Number of patients completing radiotherapy and three cycles of chemotherapy with no delay
Interventions
- OTHER Placebo
- DRUG Beetroot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-05-01 |
| Phase | Phase 2 |
What the finished NCT02058849 record still lists
NCT02058849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02058849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02058849 about?
NCT02058849 is a clinical study titled "Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck". The objective of the current proposal is to determine if concentrated beet root could improve medical treatment compliance as defined by completion of radiotherapy and 3 cycles of chemoradiation without dose reduction, preserve fat-free mass, and strength while reducing mucositis. The investigators ...
What is the current status of trial NCT02058849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2014-12. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT02058849?
The interventions under investigation include: Placebo (OTHER), Beetroot (DRUG).
Who is sponsoring clinical trial NCT02058849?
This trial is sponsored by David Travis Thomas, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02058849's enrollment target sits among peer trials
13 1947th of 2000 higher than 53 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia